Copyright Reports & Markets. All rights reserved.

Global Extracorporeal Blood Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Extracorporeal Blood Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Extracorporeal Blood Treatment by Type
    • 1.3.1 Overview: Global Extracorporeal Blood Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Extracorporeal Blood Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Hemodialysis
    • 1.3.4 Acute dialysis
    • 1.3.5 Apheresis
  • 1.4 Global Extracorporeal Blood Treatment Market by Application
    • 1.4.1 Overview: Global Extracorporeal Blood Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Severe Sepsis
    • 1.4.3 Acute Lung Injury
    • 1.4.4 Liver Failure
    • 1.4.5 Cardiogenic Shock
  • 1.5 Global Extracorporeal Blood Treatment Market Size & Forecast
  • 1.6 Global Extracorporeal Blood Treatment Market Size and Forecast by Region
    • 1.6.1 Global Extracorporeal Blood Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Extracorporeal Blood Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Extracorporeal Blood Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Extracorporeal Blood Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Extracorporeal Blood Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Extracorporeal Blood Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Extracorporeal Blood Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Fresenius Medical Care
    • 2.1.1 Fresenius Medical Care Details
    • 2.1.2 Fresenius Medical Care Major Business
    • 2.1.3 Fresenius Medical Care Extracorporeal Blood Treatment Product and Solutions
    • 2.1.4 Fresenius Medical Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Fresenius Medical Care Recent Developments and Future Plans
  • 2.2 DaVita Kidney Care
    • 2.2.1 DaVita Kidney Care Details
    • 2.2.2 DaVita Kidney Care Major Business
    • 2.2.3 DaVita Kidney Care Extracorporeal Blood Treatment Product and Solutions
    • 2.2.4 DaVita Kidney Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 DaVita Kidney Care Recent Developments and Future Plans
  • 2.3 Renal Care
    • 2.3.1 Renal Care Details
    • 2.3.2 Renal Care Major Business
    • 2.3.3 Renal Care Extracorporeal Blood Treatment Product and Solutions
    • 2.3.4 Renal Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Renal Care Recent Developments and Future Plans
  • 2.4 Dialysis Clinic
    • 2.4.1 Dialysis Clinic Details
    • 2.4.2 Dialysis Clinic Major Business
    • 2.4.3 Dialysis Clinic Extracorporeal Blood Treatment Product and Solutions
    • 2.4.4 Dialysis Clinic Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Dialysis Clinic Recent Developments and Future Plans
  • 2.5 American Renal Associates
    • 2.5.1 American Renal Associates Details
    • 2.5.2 American Renal Associates Major Business
    • 2.5.3 American Renal Associates Extracorporeal Blood Treatment Product and Solutions
    • 2.5.4 American Renal Associates Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 American Renal Associates Recent Developments and Future Plans
  • 2.6 Satellite Healthcare
    • 2.6.1 Satellite Healthcare Details
    • 2.6.2 Satellite Healthcare Major Business
    • 2.6.3 Satellite Healthcare Extracorporeal Blood Treatment Product and Solutions
    • 2.6.4 Satellite Healthcare Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Satellite Healthcare Recent Developments and Future Plans
  • 2.7 Atlantic Dialysis Management
    • 2.7.1 Atlantic Dialysis Management Details
    • 2.7.2 Atlantic Dialysis Management Major Business
    • 2.7.3 Atlantic Dialysis Management Extracorporeal Blood Treatment Product and Solutions
    • 2.7.4 Atlantic Dialysis Management Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Atlantic Dialysis Management Recent Developments and Future Plans
  • 2.8 Northwest Kidney Centers
    • 2.8.1 Northwest Kidney Centers Details
    • 2.8.2 Northwest Kidney Centers Major Business
    • 2.8.3 Northwest Kidney Centers Extracorporeal Blood Treatment Product and Solutions
    • 2.8.4 Northwest Kidney Centers Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Northwest Kidney Centers Recent Developments and Future Plans
  • 2.9 Centers for Dialyssis Care
    • 2.9.1 Centers for Dialyssis Care Details
    • 2.9.2 Centers for Dialyssis Care Major Business
    • 2.9.3 Centers for Dialyssis Care Extracorporeal Blood Treatment Product and Solutions
    • 2.9.4 Centers for Dialyssis Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Centers for Dialyssis Care Recent Developments and Future Plans
  • 2.10 Rogosin Institute
    • 2.10.1 Rogosin Institute Details
    • 2.10.2 Rogosin Institute Major Business
    • 2.10.3 Rogosin Institute Extracorporeal Blood Treatment Product and Solutions
    • 2.10.4 Rogosin Institute Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Rogosin Institute Recent Developments and Future Plans
  • 2.11 B. Braun
    • 2.11.1 B. Braun Details
    • 2.11.2 B. Braun Major Business
    • 2.11.3 B. Braun Extracorporeal Blood Treatment Product and Solutions
    • 2.11.4 B. Braun Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 B. Braun Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Extracorporeal Blood Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Extracorporeal Blood Treatment by Company Revenue
    • 3.2.2 Top 3 Extracorporeal Blood Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Extracorporeal Blood Treatment Players Market Share in 2023
  • 3.3 Extracorporeal Blood Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Extracorporeal Blood Treatment Market: Region Footprint
    • 3.3.2 Extracorporeal Blood Treatment Market: Company Product Type Footprint
    • 3.3.3 Extracorporeal Blood Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Extracorporeal Blood Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Extracorporeal Blood Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Extracorporeal Blood Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Extracorporeal Blood Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Extracorporeal Blood Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Extracorporeal Blood Treatment Consumption Value by Application (2019-2030)
  • 6.3 North America Extracorporeal Blood Treatment Market Size by Country
    • 6.3.1 North America Extracorporeal Blood Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Extracorporeal Blood Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Extracorporeal Blood Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Extracorporeal Blood Treatment Market Size by Country
    • 7.3.1 Europe Extracorporeal Blood Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Extracorporeal Blood Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Extracorporeal Blood Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Extracorporeal Blood Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Extracorporeal Blood Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Extracorporeal Blood Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Extracorporeal Blood Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Extracorporeal Blood Treatment Market Size by Country
    • 9.3.1 South America Extracorporeal Blood Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Extracorporeal Blood Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Extracorporeal Blood Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Extracorporeal Blood Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Extracorporeal Blood Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Extracorporeal Blood Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Extracorporeal Blood Treatment Market Drivers
  • 11.2 Extracorporeal Blood Treatment Market Restraints
  • 11.3 Extracorporeal Blood Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Extracorporeal Blood Treatment Industry Chain
  • 12.2 Extracorporeal Blood Treatment Upstream Analysis
  • 12.3 Extracorporeal Blood Treatment Midstream Analysis
  • 12.4 Extracorporeal Blood Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Extracorporeal Blood Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Extracorporeal Blood Treatment industry chain, the market status of Severe Sepsis (Hemodialysis, Acute dialysis), Acute Lung Injury (Hemodialysis, Acute dialysis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Extracorporeal Blood Treatment.
    Regionally, the report analyzes the Extracorporeal Blood Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Extracorporeal Blood Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Extracorporeal Blood Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Extracorporeal Blood Treatment industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hemodialysis, Acute dialysis).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Extracorporeal Blood Treatment market.
    Regional Analysis: The report involves examining the Extracorporeal Blood Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Extracorporeal Blood Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Extracorporeal Blood Treatment:
    Company Analysis: Report covers individual Extracorporeal Blood Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Extracorporeal Blood Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Severe Sepsis, Acute Lung Injury).
    Technology Analysis: Report covers specific technologies relevant to Extracorporeal Blood Treatment. It assesses the current state, advancements, and potential future developments in Extracorporeal Blood Treatment areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Extracorporeal Blood Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Extracorporeal Blood Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Hemodialysis
    Acute dialysis
    Apheresis
    Market segment by Application
    Severe Sepsis
    Acute Lung Injury
    Liver Failure
    Cardiogenic Shock
    Market segment by players, this report covers
    Fresenius Medical Care
    DaVita Kidney Care
    Renal Care
    Dialysis Clinic
    American Renal Associates
    Satellite Healthcare
    Atlantic Dialysis Management
    Northwest Kidney Centers
    Centers for Dialyssis Care
    Rogosin Institute
    B. Braun
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Extracorporeal Blood Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Extracorporeal Blood Treatment, with revenue, gross margin and global market share of Extracorporeal Blood Treatment from 2019 to 2024.
    Chapter 3, the Extracorporeal Blood Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Extracorporeal Blood Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Extracorporeal Blood Treatment.
    Chapter 13, to describe Extracorporeal Blood Treatment research findings and conclusion.

    Buy now